These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 26830609

  • 41. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma.
    Bernstine H, Braun M, Yefremov N, Lamash Y, Carmi R, Stern D, Steinmetz A, Sosna J, Groshar D.
    Radiology; 2011 Aug; 260(2):503-10. PubMed ID: 21555347
    [Abstract] [Full Text] [Related]

  • 42. Prognostic PET [11C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma - a bench to bed study.
    Chiu KWH, Tan KV, Yang X, Zhu X, Shi J, Chiang CL, Chan L, Hui Y, Khong PL, Man K, Wong JWH.
    Cancer Imaging; 2024 Mar 22; 24(1):42. PubMed ID: 38520026
    [Abstract] [Full Text] [Related]

  • 43. Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
    Zhu D, Wang Y, Wang L, Chen J, Byanju S, Zhang H, Liao M.
    Acta Radiol; 2018 Sep 22; 59(9):1082-1090. PubMed ID: 29256260
    [Abstract] [Full Text] [Related]

  • 44. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
    Piduru SM, Schuster DM, Barron BJ, Dhanasekaran R, Lawson DH, Kim HS.
    J Vasc Interv Radiol; 2012 Jul 22; 23(7):943-8. PubMed ID: 22609292
    [Abstract] [Full Text] [Related]

  • 45. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with small hepatocellular carcinoma treated by radiofrequency ablation.
    Ida Y, Tamai H, Shingaki N, Shimizu R, Maeshima S, Maekita T, Iguchi M, Terada M, Kitano M.
    Cancer Imaging; 2020 Oct 19; 20(1):74. PubMed ID: 33076990
    [Abstract] [Full Text] [Related]

  • 46. Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy.
    Paudyal B, Oriuchi N, Paudyal P, Tsushima Y, Iida Y, Higuchi T, Hanaoka H, Miyakubo M, Takano A, Ishikita T, Endo K.
    Oncol Rep; 2007 Dec 19; 18(6):1469-73. PubMed ID: 17982632
    [Abstract] [Full Text] [Related]

  • 47. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
    Hatano E, Ikai I, Higashi T, Teramukai S, Torizuka T, Saga T, Fujii H, Shimahara Y.
    World J Surg; 2006 Sep 19; 30(9):1736-41. PubMed ID: 16850145
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Tumor-to-muscle ratio of 8F-FDG PET for predicting histologic features and recurrence of HCC.
    Baek YH, Lee SW, Jeong YJ, Jeong JS, Roh YH, Han SY.
    Hepatogastroenterology; 2015 Sep 19; 62(138):383-8. PubMed ID: 25916068
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis.
    Pan L, Gu P, Huang G, Xue H, Wu S.
    Eur J Gastroenterol Hepatol; 2009 Sep 19; 21(9):1008-15. PubMed ID: 19352191
    [Abstract] [Full Text] [Related]

  • 53. Prognostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with combined hepatocellular-cholangiocarcinoma.
    Lim CH, Moon SH, Cho YS, Choi JY, Lee KH, Hyun SH.
    Eur J Nucl Med Mol Imaging; 2019 Jul 19; 46(8):1705-1712. PubMed ID: 31049603
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Diagnostic test accuracies of F-18 FDG PET/CT for prediction of microvascular invasion of hepatocellular carcinoma: A meta-analysis.
    Kim K, Kim SJ.
    Clin Imaging; 2021 Nov 19; 79():251-258. PubMed ID: 34157501
    [Abstract] [Full Text] [Related]

  • 56. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT, Kim JK, Kim DY, Ahn SH, Lee JD, Yun M, Rha SY, Chon CY, Han KH.
    Oncology; 2007 Nov 19; 72 Suppl 1():104-10. PubMed ID: 18087190
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
    Izuishi K, Yamamoto Y, Mori H, Kameyama R, Fujihara S, Masaki T, Suzuki Y.
    Oncol Rep; 2014 Feb 19; 31(2):701-6. PubMed ID: 24297035
    [Abstract] [Full Text] [Related]

  • 60. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
    Park JW, Kim JH, Kim SK, Kang KW, Park KW, Choi JI, Lee WJ, Kim CM, Nam BH.
    J Nucl Med; 2008 Dec 19; 49(12):1912-21. PubMed ID: 18997056
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.